MARKET

PHGE

PHGE

Biomx Inc
AMEX
0.1588
-0.0062
-3.76%
After Hours: 0.1598 +0.001 +0.63% 19:41 08/11 EDT
OPEN
0.1608
PREV CLOSE
0.1650
HIGH
0.1639
LOW
0.1530
VOLUME
670.09K
TURNOVER
--
52 WEEK HIGH
12.29
52 WEEK LOW
0.1192
MARKET CAP
1.87M
P/E (TTM)
-0.0064
1D
5D
1M
3M
1Y
5Y
1D
BiomX Invests in MEA Motor and Drone Testing
TipRanks · 2h ago
Weekly Report: what happened at PHGE last week (0803-0807)?
Weekly Report · 1d ago
BiomX acquires 10% stake in Motomea to expand drone testing capabilities
Seeking Alpha · 6d ago
Press Release: BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems
Dow Jones · 6d ago
Weekly Report: what happened at PHGE last week (0727-0731)?
Weekly Report · 08/03 09:12
BiomX Amends Promissory Note, Issues Restricted Shares
TipRanks · 07/28 13:49
BiomX Amends Zorronet Acquisition Note, Issues 800,000 Restricted Shares To Water.IO For Payment Flexibility
Benzinga · 07/28 13:17
*BiomX: Final Maturity Date of $1.25 M Promissory Note Held by Water.IO Ltd. Extended to Nov 1>PHGE
Dow Jones · 07/28 13:17
More
About PHGE
BiomX Inc. is a clinical stage product discovery company developing products using both natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases, such as diabetic foot infections, or DFI. Bacteriophage or phage are bacterial, species-specific, strain-limited viruses that infect, amplify and kill the target bacteria and are considered inert to mammalian cells. By utilizing proprietary combinations of naturally occurring phage and creating novel phage using synthetic biology, it develops phage-based therapies intended to address large-market diseases. The Company offers two phage-based product types: Fixed cocktail therapy and Personalized therapy. Its ongoing programs include BX011 and BX211. BX011 is a fixed multi-phage cocktail, for the treatment of DFI associated with Staphylococcus aureus (S. aureus). BX211 is a phage therapy for the treatment of Diabetic Foot Osteomyelitis (DFO) associated with S. aureus.

Webull offers Biomx Inc stock information, including AMEX: PHGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHGE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHGE stock methods without spending real money on the virtual paper trading platform.